Author

Ritsuko Oikawa

Observed names: Oikawa, R., R. Oikawa, was modified to produce recombinant EBV and was used as a source of the virus. G418-resistant cell clones were isolated by incubation in medium containing 500 ng/ml of G418. After selection with G418, 及川律子
ORCID: 0000-0003-0444-0081
Observed ORCID: 0000-0003-0444-0081
OpenAlex ID: A5012700645
2011 · Yoshiyuki Watanabe, Ryan J. Castoro, et al. · PLoS ONE · 74
2011 · Yoshichika Oishi, Yoshiyuki Watanabe, et al. · Tumor Biology · 54
2022 · Kumiko Umemoto, Hiroyuki Yamamoto, et al. · JNCI Journal of the National Cancer Institute · 28
2017 · Hirofumi Kiyokawa, Hiroshi Yasuda, et al. · Cancer Science · 27
2011 · Satoshi Baba, Yoshichika Oishi, et al. · Digestion · 18
2013 · Y. Nagai, E. Hashimoto, et al. · Diabetes Obesity and Metabolism · 16
2012 · Ryota Hama, Yoshiyuki Watanabe, et al. · Tumor Biology · 15
2022 · Yasumasa Matsuo, Yosuke Igarashi, et al. · Clinical Journal of Gastroenterology · 14
2016 · Shuichi Miyamoto, Yoshiyuki Watanabe, et al. · Tumor Biology · 10
2018 · Yasumasa Matsuo, Hiroyuki Yamamoto, et al. · Clinical Journal of Gastroenterology · 9
2021 · Yoshiyuki Watanabe, Ritsuko Oikawa, et al. · Journal of Clinical Laboratory Analysis · 8
2013 · Yosuke Michikawa, Hiroshi Yasuda, et al. · Clinical Medicine Insights Gastroenterology · 5
Works count: 67
Citation count: 624
H-index: 14
I10-index: 18
Year
Topic
Type